Search research articles
Contact Us
Filters
Showing results (271-280 of 284) with videos related to
Page
of 29
Sort By:
Clinical and Experimental Dermatology
|
July 15, 2025
Therapeutic Outcomes Across JAK Inhibitors in Prurigo Nodularis
Gianluca Avallone, Andrea Bombelli, Luca Valtellini, et al.
Dermatology and Therapy
|
May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)
Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Dermatology and Therapy
|
October 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study
Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo, et al.
Clinical and Experimental Dermatology
|
July 9, 2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study
Maddalena Napolitano, Giuseppe Lauletta, Marianna Cimmino, et al.
Clinical and Experimental Dermatology
|
October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
International Journal of Dermatology
|
August 21, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, et al.
Journal of Clinical Medicine
|
February 26, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Dario Graceffa, Martina Burlando, et al.
Clinical and Experimental Dermatology
|
June 11, 2024
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients
Silvia Ferrucci, Simona Tavecchio, Carlo Alberto Maronese, et al.
The Journal of Dermatological Treatment
|
August 15, 2023
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 26, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study
Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 284) with videos related to
Sort By:
Page
of 29
Clinical and Experimental Dermatology
|
July 15, 2025
Therapeutic Outcomes Across JAK Inhibitors in Prurigo Nodularis
Gianluca Avallone, Andrea Bombelli, Luca Valtellini, et al.
Dermatology and Therapy
|
May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)
Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Dermatology and Therapy
|
October 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study
Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo, et al.
Clinical and Experimental Dermatology
|
July 9, 2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study
Maddalena Napolitano, Giuseppe Lauletta, Marianna Cimmino, et al.
Clinical and Experimental Dermatology
|
October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
International Journal of Dermatology
|
August 21, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, et al.
Journal of Clinical Medicine
|
February 26, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Dario Graceffa, Martina Burlando, et al.
Clinical and Experimental Dermatology
|
June 11, 2024
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients
Silvia Ferrucci, Simona Tavecchio, Carlo Alberto Maronese, et al.
The Journal of Dermatological Treatment
|
August 15, 2023
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 26, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study
Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak, et al.
Page
of 29